The current health crisis has irrevocably altered the pharmaceutical industry, necessitating new approaches to HCP and patient engagement. These major market disruptions require biopharmaceutical sales, marketing, and operations professionals to leverage analytics and adopt innovative approaches including digital capabilities to support their customers and communities to improve outcomes.
Join us for a roundtable discussion with leading industry innovators to discuss how biopharma manufacturers can successfully increase and improve HCP engagement.
Topics will include:
- Considerations on channel mix optimization that increase HCP access
- Skills for effective remote detailing
- Techniques to improve collaboration that increase leads and generate sales
- Trends that support collaborative sales and marketing initiatives